The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Open accessAbstract
Lysophospholipids encompass a diverse range of small, membrane‐derived phospholipids that act as extracellular signals. The signalling properties are mediated by 7‐transmembrane GPCRs, constituent members of which have continued to be identified after their initial discovery in the mid‐1990s. Here we briefly review this class of receptors, with a particular emphasis on their protein and gene nomenclatures that reflect their cognate ligands. There are six lysophospholipid receptors that interact with lysophosphatidic acid (LPA): protein names LPA 1 – LPA6 and italicized gene names LPAR1‐LPAR6 (human) and Lpar1‐Lpar6 (non‐human). There are five sphingosine 1‐phosphate (S1P) receptors: protein names S1P 1‐S1P 5 and italicized gene names S1PR1‐S1PR5 (human) and S1pr1‐S1pr5 (non‐human). Recent additions to the lysophospholipid receptor family have resulted in the proposed names for a lysophosphatidyl inositol (LPI) receptor – protein name LPI 1 and gene name LPIR1 (human) and Lpir1 (non‐human) – and three lysophosphatidyl serine receptors – protein names LyPS 1, LyPS 2, LyPS 3 and gene names LYPSR1‐LYPSR3 (human) and Lypsr1‐Lypsr3 (non‐human) along with a variant form that does not appear to exist in humans that is provisionally named LyPS 2L. This nomenclature incorporates previous recommendations from the International U nion of B asic and C linical P harmacology, the H uman G enome O rganization, the Gene Nomenclature Committee, and the M ouse G enome I nformatix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–212 of 212
Sugita, K., Yamamura, C., Tabata, K.-I., & Fujita, N. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.046 · Cited by 39
Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts
Rapizzi, E., Donati, C., Cencetti, F., Nincheri, P., & Bruni, P. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9780-y · Cited by 38
PTPL1/FAP-1 Negatively Regulates TRIP6 Function in Lysophosphatidic Acid-induced Cell Migration
Lai, Y., Lin, W.-C., & Lin, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701499200 · Cited by 37
Musazzi, L., Daniel, E. D., Maycox, P. R., Racagni, G., & Popoli, M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001240 · Cited by 36
Roles for lysophospholipid S1P receptors in multiple sclerosis
Noguchi, K., & Chun, J. J. M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.522975 · Cited by 35
Self-citationSukocheva, O. A., Wadham, C., & Xia, P. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.10.014 · Cited by 35
Lysophosphatidic Acid Modulates the Activation of Human Monocyte-Derived Dendritic Cells
Chen, R., Roman, J. A., Guo, J., West, E. E., McDyer, J. F., Williams, M. A., & Georas, S. N. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.797 · Cited by 33
Olivera, A., Dillahunt, S., & Rivera, J. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.01.005 · Cited by 28
Kotsikorou, E., Lynch, D. L., Abood, M. E., & Reggio, P. H. (2010) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2010.12.003 · Cited by 25
GPR34 as a lysophosphatidylserine receptor
Makide, K., & Aoki, J. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt010 · Cited by 23
Nobusue, H., Kondo, D., Yamamoto, M., & Kano, K. (2010) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2010.08.010 · Cited by 19
Jacobi, F. K., Broghammer, M., Pesch, K., Zrenner, E., Berger, W., Meindl, A., & Pusch, C. M. (2000) · Human Genetics · doi:10.1007/s004390000337 · Cited by 14
Cited by
Illuminating G-Protein-Coupling Selectivity of GPCRs
Inoue, A., Raimondi, F., Kadji, F. M. N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.044 · Cited by 638
Emerging roles of lysophospholipids in health and disease
Tan, S. T., Ramesh, T., Toh, X. R., & Nguyen, L. N. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101068 · Cited by 371
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Geraldo, L. H. M., Spohr, T. C. L. D. S., Amaral, R. F. D., Fonseca, A. C. C. D., Garcia, C., Mendes, F. D. A., Freitas, C., dosSantos, M. F., & Lima, F. R. S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00367-5 · Cited by 313
Chun, J., Kihara, Y., Jonnalagadda, D., & Blaho, V. A. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021358 · Cited by 131
Self-citationPlastira, I., Bernhart, E., Goeritzer, M., Reicher, H., Kumble, V. B., Kogelnik, N., Wintersperger, A., Hammer, A., Schlager, S., Jandl, K., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0701-9 · Cited by 112
Metadata
- Authors
- Kihara, Y., Maceyka, M., Spiegel, S., & Chun, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-07-12
- Volume
- 171
- Issue
- 15
- Pages
- 3575-3594
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1549006420
- Cited by
- 324
- References
- 212
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
